Herbas VPB

Print
EN | LT
LT - PI3K inhibitorių benzoksazepino junginiai ir jų panaudojimas vėžio gydyme
EN - BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 498/04 (2006.01)
C07D 498/14 (2006.01)
C07D 519/00 (2006.01)
A61K 31/4162 (2006.01)
A61K 31/4188 (2006.01)
A61K 31/4196 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 2483278
(13) Kind of document T
(96) European patent application number 10757213.3
Date of filing the European patent application 2010-09-27
(97) Date of publication of the European application 2012-08-08
(45) Date of publication and mention of the grant of the patent 2013-12-25
(46) Date of publication of the claims translation 2014-03-25
PCT application
(86) Number PCT/EP2010/064208
Date 2010-09-27
PCT application publication
(87) Number WO 2011/036280
Date 2011-03-31
Priority applications
(30) Number Date Country code
246381 P 2009-09-28 US
330685 P 2010-05-03 US
Inventors
(72)
BLAQUIERE, Nicole, US
DO, Steven, US
DUDLEY, Danette, US
FOLKES, Adrian J., GB
HEALD, Robert, GB
HEFFRON, Timothy, US
JONES, Mark, GB
KOLESNIKOV, Aleksandr, US
NDUBAKU, Chudi, US
OLIVERO, Alan G., US
PRICE, Stephen, GB
STABEN, Steven, US
WANG, Lan, US
Grantee
(73) F. Hoffmann-La Roche AG, Grenzacherstra e 124, 4070 Basel, CH
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) PI3K inhibitorių benzoksazepino junginiai ir jų panaudojimas vėžio gydyme
  BENZOXAZEPIN PI3K INHIBITOR COMPOUNDS AND THEIR USE IN THE TREATMENT OF CANCER
Last renewal fee
Payment date Validity (years) Amount
2024-08-20 15 289.00 EUR
Next renewal fee
2025-09-27